and have an innate curiosity to find out how they act physiologically in a human being," said Suter. "Without [scientific] data, we could rely only on tradition, hearsay, or personal experiences; with these data we are credible and gain the trust of practitioners, pharmacists, and patients. Further, carrying out research allows us to find new indications for known plants and is one of the key drivers to stay innovative and successful. And last but not least, research carried out in phytotherapy helps the whole 'phytomedical' community, as we are living in times of evidence based medicine."
According to Bioforce USA President and CEO Pierce S. Sioussat, the acceptance of herbal medicine in the United States "can only be accomplished through continued investment in clinical research using commercially available products that are manufactured in a manner that ensures batch-after-batch and year-after-year consistency. It is also important that such research have a credible forum for public disclosure, and, in this regard, the American Botanical Council plays a critical role." Bioforce USA is a partner company that will accept the ABC award on Bioforce AG's behalf.
Bioforce AG's product integrity begins by honoring one of the most important philosophies of Swiss clinical herbalist Alfred Vogel, who founded the company in 1963: insisting that the plants used in its products are grown organically on its own farms or contract farms assessed for sustainability and approved by the company itself. According to Bioforce, the company also harvests at "ideal" times, uses high-quality seed varieties, allows the plants to sufficiently mature "until they reach optimum potential," and mixes harvest batches in order to ensure consistent efficacy. Suter said that the company always uses the whole plant in its products—another of Vogel's most important founding philosophies—and processes the plants within 24 hours after harvest to guarantee a "full
'/>"/>
SOURCE American Botanical Council Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related biology technology :1.
Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software2.
Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter3.
SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms4.
CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)5.
XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition6.
BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC7.
Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents8.
Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program9.
Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores10.
TorreyPines Therapeutics Receives NASDAQ Deficiency Notice11.
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery